Navigation Links
New Computer-Based Tools Will Help Make Best Use of Genetic Breast Cancer Tests
Date:9/22/2008

ROCKVILLE, Md., Sept. 22 /PRNewswire-USNewswire/ -- A new federal project, funded by the Agency for Healthcare Research and Quality, will lead efforts to develop, implement and evaluate four computer-based decision-support tools that will help clinicians and patients better use genetic tests to evaluate and treat breast cancer.

The first pair of tools will assess whether a woman with a family history of cancer should be tested for BRCA1 and BRCA2 gene mutations. Knowing whether a woman has inherited these gene mutations may help determine her chances of developing certain kinds of cancer, especially breast cancer. The second pair of tools, for women already diagnosed with breast cancer, will help determine which patients are appropriate for a Gene Expression Profiling (GEP) test. GEP test results can help evaluate which patients are at a high risk of cancer recurrence and therefore are good candidates for chemotherapy, in addition to other appropriate treatments.

"Genetic testing can be a powerful tool for assessing the risk of breast cancer and treating the disease effectively, but clinicians need better support in identifying which patients will benefit from specific tests," said AHRQ Director Carolyn M. Clancy, M.D. "This work is part of a broader effort to provide decision support tools that will help physicians and patients in achieving the best possible outcomes and improving patient care."

The $1 million project will be completed by RTI International, an independent, non-profit research institute in Research Triangle Park, N.C. It is expected to take about 16 months. It responds to recent recommendations from the U.S. Department of Health and Human Services' Secretary's Advisory Committee on Genetics, Health, and Society. The committee concluded there are extensive gaps in knowledge about genetic tests and their impact on patient care. The project also reflects the goals of HHS Secretary Mike Leavitt's priority initiative on personalized health care, which aims at increasing the effectiveness of medical care by more precisely matching each patient's conditions and needs with therapies that will be effective for them.

Development of these tools will support AHRQ's work of translating research into clinical practice in the areas of genetic tests, health information technology and patient care. For instance, the

AHRQ-sponsored U.S. Preventive Services Task Force has recommended that women whose family history is associated with an increased risk for BRCA1 or BRCA2 gene mutations are referred for genetic counseling and evaluation to measure the need for BRCA testing. AHRQ has also published an Evidence-based Practice Center report on the impact of GEP tests on breast cancer outcomes.

The new project to create decision-support tools is funded through AHRQ's DEcIDE (Developing Evidence to Inform Decisions about Effectiveness) research network, part of the Effective Health Care Program. The Effective Health Care Program sponsors the development of new scientific knowledge through studies on the outcomes of health care technologies and services. For more information about AHRQ's Effective Health Care Program and the DEcIDE Network, visit the Effective Health Care Web site at http://effectivehealthcare.ahrq.gov. To learn more about the project to create gene-based clinical decision-support tools for breast cancer patients, visit: http://effectivehealthcare.ahrq.gov/healthInfo.cfm?infotype=nr&ProcessID=68 .


'/>"/>
SOURCE Agency for Healthcare Research & Quality
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. New Michael J. Fox Foundation Initiative Will Drive Development of Web-Based Tools to Increase Patient Participation in Parkinsons Clinical Trials
2. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
3. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
4. Genetics Determine Optimal Drug Dose of Common Anticoagulant
5. CellCyte Genetics Corp. Enters Collaborative Research Agreement With Cleveland Clinic Foundation to Qualify Stem Cell Delivery in Damaged Heart Tissue
6. Targeted Genetics Reports on Recombinant DNA Advisory Committee (RAC) Review of its Phase 1/2 Trial of tgAAC94 for Rheumatoid Arthritis
7. Genetic Differences Predict Anti-Inflammatory Benefits From Nutritional Products
8. 454 Sequencing(TM) in Science Today: Researchers Uncover a Genetic Basis for Different Social Behaviors in Wasps
9. deCODE Launches deCODE MI(TM) -- A Test for a Major Genetic Risk Factor for Early-onset Heart Attack
10. Preimplantation Genetic Diagnosis International Society Refutes American Society of Reproductive Medicine Opinion - States Preimplantation Genetic Screening is Beneficial When Performed in Experienced Centers
11. American Fertility Association Calls for Expanded Research to Advance New Technology to Screen Embryos for Genetic Abnormalities
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/16/2017)... , January 16, 2017 ... Derivatives Market by Product Type (Methyl, Ethyl, Hydroxyethyl, ... Foods & Beverages, Surface Coatings & Paints), ... by MarketsandMarkets, the market was valued at ... projected to reach USD 6.41 Billion by ...
(Date:1/16/2017)... , Jan. 16, 2017  Dovetail Genomics today announced ... and assembly service, which yields chromosome-scale genome assemblies. The ... a Dovetail-hosted workshop on Jan. 17 at the Plant ... San Diego . "We are thrilled ... launch of our Dovetail Hi-C offering," said Todd ...
(Date:1/15/2017)... , January 16, 2017 Der ... Kollagenprodukten für die Regeneration des menschlichen Gewebes, gibt die ... mit sofortiger Wirkung bekannt. ... Bill Allan ... Er bekleidete eine Reihe von Geschäftsführer- und anderen Führungspositionen ...
Breaking Medicine Technology:
(Date:1/15/2017)... ... January 15, 2017 , ... Accreditation Commission for ... for its specialty care services. Albertsons Companies is the largest national food ... for pharmacy patients. , Accreditation by ACHC reflects Albertsons Companies’ dedication and commitment ...
(Date:1/15/2017)... IL (PRWEB) , ... January 14, 2017 , ... Wondering ... Lobster Gram Dinner delivered straight to your door for a romantic, lobster feast in ... just in time for Valentine's Day. The dinners will be featured until February ...
(Date:1/14/2017)... ... 14, 2017 , ... Healthy living brand Moody Zook recently ... products. With more and more people opting to go organic in their lifestyle, ... cater to specific needs. , Moody Zook focused particularly on their newly launched ...
(Date:1/14/2017)... (PRWEB) , ... January 14, 2017 , ... "TransFreeze Volume 3 is a self animating ... mask effect in Final Cut Pro X," said Christina Austin - CEO of Pixel Film ... a unique freeze frame transition from one clip to the next. , To ...
(Date:1/13/2017)... ... January 13, 2017 , ... A January 10 article ... for 2017 according to the publication, with an emphasis on some new techniques that ... F.I.C.S., F.A.C.S., who is known more casually to his patients and colleagues as Dr. ...
Breaking Medicine News(10 mins):